ENOVEnovis Corporation
24.42USD+0.95%Mkt Cap: 1.41B USDP/E: Last update: 2026-05-26

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconst…

Indicators:|

Key Statistics

Company
Market Cap1.41B USD
Enterprise Value2.80B USD
Revenue (TTM)2.28B USD
Gross Profit1.35B USD
Net Income (TTM)-1.18B USD
Revenue/Share39.83 USD
Last Price24.42 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees7.8K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)
P/E (Forward)6.05
PEG3.45
EV/EBITDA7.51
EV/Revenue1.23
P/S0.62
P/B0.96
EPS (TTM)-19.89
EPS (Forward)4.06
52W Range
21.0022% of range36.82
52W High36.82 USD
52W Low21.00 USD
Profitability
Gross Margin59.84%
Oper. Margin3.64%
EBITDA Margin16.34%
Profit Margin-52.69%
ROE-79.51%
ROA-30.89%
Growth
Revenue Growth5.40%
Earnings Growth
Cash Flow & Leverage
Operating CF217.29M USD
CapEx (TTM)197.38M USD
FCF Margin9.08%
FCF Yield14.65%
Net Debt1.38B USD
Net Debt/EBITDA3.70
Balance Sheet
Debt/Equity0.93
Current Ratio2.04
Quick Ratio0.78
Book Value/Sh25.66 USD
Cash/Share0.5760 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split581:1000
Split DateApr 5, 2022
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)43.00 USD
Target Range33.00 USD55.00 USD
# Analysts11
Ownership
Shares Out.57.56M
Float56.75M
Insiders1.47%
Institutions119.75%
Short Interest
Short Ratio11.4d
Short % Float19.12%
Short % Out.16.04%
Shares Short9.23M
Short (prev mo.)8.15M
Technical
SMA 5024.02 (+1.7%)
SMA 20027.05 (-9.7%)
Beta1.52
S&P 52W Chg28.31%
Avg Vol (30d)1.07M
Avg Vol (10d)1.31M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)